BABA vs BBWI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BBWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock appears undervalued based on a low P/E of 6.87 and an intrinsic value estimate of $22.61, close to the current price of $22.20. However, declining revenue and earnings growth, along with negative Price/Book, raise sustainability concerns. While profitability margins and ROA are strong relative to peers, weak recent earnings surprises and bearish technical trends cap upside potential.